Extended treatment with selective phosphatidylinositol 3-kinase and m TOR inhibitors has effects on metabolism, growth, behaviour and bone strength.

MLA

Smith, Greg C., et al. “Extended Treatment with Selective Phosphatidylinositol 3-Kinase and m TOR Inhibitors Has Effects on Metabolism, Growth, Behaviour and Bone Strength.” FEBS Journal, vol. 280, no. 21, Nov. 2013, pp. 5337–49. EBSCOhost, https://doi.org/10.1111/febs.12428.

APA

Smith, G. C., Ong, W. ‐ K., Costa, J. L., Watson, M., Cornish, J., Grey, A., Gamble, G. D., Dickinson, M., Leung, S., Rewcastle, G. W., Han, W., & Shepherd, P. R. (2013). Extended treatment with selective phosphatidylinositol 3-kinase and m TOR inhibitors has effects on metabolism, growth, behaviour and bone strength. FEBS Journal, 280(21), 5337–5349. https://doi.org/10.1111/febs.12428

Chicago

Smith, Greg C., Wee ‐ Kiat Ong, Jessica L. Costa, Maureen Watson, Jillian Cornish, Andrew Grey, Greg D. Gamble, et al. 2013. “Extended Treatment with Selective Phosphatidylinositol 3-Kinase and m TOR Inhibitors Has Effects on Metabolism, Growth, Behaviour and Bone Strength.” FEBS Journal 280 (21): 5337–49. doi:10.1111/febs.12428.